Please use this identifier to cite or link to this item:
Transgenic fish – where we are and where do we go?
|Title:||Transgenic fish – where we are and where do we go?|
|Authors:||Dunham, Rex A.|
|Keywords:||transgenic fish, gene transfer, growth, disease resistance, commercialization|
|LC Subject Headings:||Fish culture--Israel--Periodicals.|
|Publisher:||Israeli Journal of Aquaculture - BAMIGDEH|
|Citation:||Dunham, R.A., & Liu, Z. (2006). Transgenic fish – where we are and where do we go?. The Israeli Journal of Aquaculture - Bamidgeh, 58(4), 297-319.|
|Series/Report no.:||The Israeli Journal of Aquaculture - Bamidgeh|
|Abstract:||Transgenic fish have been developed that have improved growth, color, disease resistance, sur- vival in cold, and body composition, and produce pharmaceutical proteins. Transgenes elicit pleiotropic effects, some positive and some negative. In general, transgenic fish appear to have lower fitness than controls and pose little environmental risk, but this research is not fully con- clusive. Transgenic zebrafish with altered coloration have been commercialized and growth hor- mone transgenic salmon, carp, and tilapia are near commercialization. To enhance commer- cialization and minimize environmental risk, additional technologies such as transgenic steriliza- tion need to be developed. Genomic research has produced an abundance of molecular genet- ic information including many genes for consideration for gene transfer, highly regulated gene promoters, and knowledge about their expression and function. Functional genomics analysis should be applied in the future to enhance the capacity and versatility of transgenic technology.|
|Appears in Collections:||IJA Volume 58, Issue 4, 2006|
Please contact email@example.com if you need this content in an alternative format.
Items in eVols are protected by copyright, with all rights reserved, unless otherwise indicated.